Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflamm...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:060788058e9c4fc49ee3f56cccaea6ae |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:060788058e9c4fc49ee3f56cccaea6ae2021-11-25T16:47:15ZCirculating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data10.3390/biology101111292079-7737https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae2021-11-01T00:00:00Zhttps://www.mdpi.com/2079-7737/10/11/1129https://doaj.org/toc/2079-7737Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflammatory bowel diseases and liver dysfunctions, which occur more frequently in PSO and LP. Serum MAdCAM-1 and ITGB7 levels in patients with plaque PSO and eruptive LP have never been studied before. The study included 42 patients with PSO, 13 with LP, and 23 controls. Serum molecules levels were evaluated using the immune–enzymatic method. ITGB7 concentration was not statistically different, both in patients with PSO and LP, compared to controls (both <i>p</i> > 0.05). MAdCAM-1 level was significantly lower in PSO subjects than in controls (<i>p</i> = 0.041), whereas in the LP group, a downward trend was observed (<i>p</i> = 0.088) with <i>p</i> = 0.0455 in ANOVA. Multiple linear regression revealed independent associations between ITGB7 and HDL and BMI and RBC in the LP group. In psoriatic patients with elevated CRP, there was an upward trend for MAdCAM-1, and also a positive correlation between MAdCAM-1 and WBC. ITGB7 and MAdCAM-1 cannot serve as markers of disease activity or liver pathology neither in patients with PSO nor LP. MAdCAM-1 might play a role as an inflammation indicator in PSO and a beneficial influence on the lipid profile in LP.Anna BaranJulia NowowiejskaTomasz W. KamińskiJulita A. KrahelIwona FlisiakMDPI AGarticlepsoriasislichen planusα<sub>4</sub>β<sub>7</sub> integrinMAdCAM-1ITGB7mucosal addressin cell adhesion molecule-1Biology (General)QH301-705.5ENBiology, Vol 10, Iss 1129, p 1129 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
psoriasis lichen planus α<sub>4</sub>β<sub>7</sub> integrin MAdCAM-1 ITGB7 mucosal addressin cell adhesion molecule-1 Biology (General) QH301-705.5 |
spellingShingle |
psoriasis lichen planus α<sub>4</sub>β<sub>7</sub> integrin MAdCAM-1 ITGB7 mucosal addressin cell adhesion molecule-1 Biology (General) QH301-705.5 Anna Baran Julia Nowowiejska Tomasz W. Kamiński Julita A. Krahel Iwona Flisiak Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
description |
Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflammatory bowel diseases and liver dysfunctions, which occur more frequently in PSO and LP. Serum MAdCAM-1 and ITGB7 levels in patients with plaque PSO and eruptive LP have never been studied before. The study included 42 patients with PSO, 13 with LP, and 23 controls. Serum molecules levels were evaluated using the immune–enzymatic method. ITGB7 concentration was not statistically different, both in patients with PSO and LP, compared to controls (both <i>p</i> > 0.05). MAdCAM-1 level was significantly lower in PSO subjects than in controls (<i>p</i> = 0.041), whereas in the LP group, a downward trend was observed (<i>p</i> = 0.088) with <i>p</i> = 0.0455 in ANOVA. Multiple linear regression revealed independent associations between ITGB7 and HDL and BMI and RBC in the LP group. In psoriatic patients with elevated CRP, there was an upward trend for MAdCAM-1, and also a positive correlation between MAdCAM-1 and WBC. ITGB7 and MAdCAM-1 cannot serve as markers of disease activity or liver pathology neither in patients with PSO nor LP. MAdCAM-1 might play a role as an inflammation indicator in PSO and a beneficial influence on the lipid profile in LP. |
format |
article |
author |
Anna Baran Julia Nowowiejska Tomasz W. Kamiński Julita A. Krahel Iwona Flisiak |
author_facet |
Anna Baran Julia Nowowiejska Tomasz W. Kamiński Julita A. Krahel Iwona Flisiak |
author_sort |
Anna Baran |
title |
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
title_short |
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
title_full |
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
title_fullStr |
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
title_full_unstemmed |
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data |
title_sort |
circulating madcam-1 and itgb7 in patients with plaque psoriasis and eruptive lichen planus—preliminary data |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae |
work_keys_str_mv |
AT annabaran circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata AT julianowowiejska circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata AT tomaszwkaminski circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata AT julitaakrahel circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata AT iwonaflisiak circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata |
_version_ |
1718412937708699648 |